GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has ploughed £125m into its African manufacturing and research operations. Here, Owain Bennallack analyses this decision…
https://youtu.be/X2MT-svv8lk
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.
VIDEO: One Fool takes a closer look at movements at GlaxoSmithKline plc (LON:GSK).
You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has ploughed £125m into its African manufacturing and research operations. Here, Owain Bennallack analyses this decision…
https://youtu.be/X2MT-svv8lk